We are live on ! Find out more
MLAB icon

Mesa Laboratories

109 hedge funds and large institutions have $614M invested in Mesa Laboratories in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

22% more capital invested

Capital invested by funds: $502M → $614M (+$112M)

19% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 36

6.3% more ownership

Funds ownership: 70.3%76.6% (+6.3%)

2% more funds holding

Funds holding: 107109 (+2)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
2.43%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
15
Increased
43
Reduced
36
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
YMRC
51
Yorktown Management & Research Company
Virginia
$866K +$48.2K +247 +6%
Brown Advisory
52
Brown Advisory
Maryland
$859K -$349K -1,788 -30%
AllianceBernstein
53
AllianceBernstein
Tennessee
$767K
Millennium Management
54
Millennium Management
New York
$743K -$5.18M -26,586 -88%
Envestnet Asset Management
55
Envestnet Asset Management
Illinois
$722K +$676K +3,464 New
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$688K -$137K -700 -18%
Citadel Advisors
57
Citadel Advisors
Florida
$575K -$107K -551 -17%
AQR Capital Management
58
AQR Capital Management
Connecticut
$525K -$254K -1,304 -34%
ACI
59
Alpha Cubed Investments
California
$507K -$14.6K -75 -3%
Neuberger Berman Group
60
Neuberger Berman Group
New York
$475K -$17.6K -90 -4%
AIG
61
American International Group
New York
$461K -$3.31K -17 -0.8%
EGM
62
Engineers Gate Manager
New York
$454K +$26.9K +138 +7%
Manulife (Manufacturers Life Insurance)
63
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$429K +$159K +816 +66%
MCM
64
Manchester Capital Management
Vermont
$422K
KeyBank National Association
65
KeyBank National Association
Ohio
$417K
Truist Financial
66
Truist Financial
North Carolina
$415K +$20.5K +105 +6%
Goldman Sachs
67
Goldman Sachs
New York
$404K -$1.67M -8,558 -82%
ARTA
68
A.R.T. Advisors
New York
$401K -$432K -2,215 -54%
Cambridge Investment Research Advisors
69
Cambridge Investment Research Advisors
Iowa
$390K
WG
70
Winton Group
United Kingdom
$361K +$338K +1,734 New
FDCDDQ
71
Federation des caisses Desjardins du Quebec
Quebec, Canada
$353K
Mackenzie Financial
72
Mackenzie Financial
Ontario, Canada
$344K +$322K +1,650 New
NA
73
Navellier & Associates
Nevada
$333K -$19.3K -99 -6%
SIA
74
Sit Investment Associates
Minnesota
$333K +$48.8K +250 +19%
VCM
75
Virtue Capital Management
Tennessee
$327K -$306K -1,570 -50%

MLAB Hedge Fund Activity: Q4 2018 in Review

109 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2018, worth a combined $614M — up 22% from $502M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new MLAB positions and 12 closed out — a net gain of 3 holders — while 43 added to existing stakes and 36 trimmed.

The largest buyer was Atlanta Capital Management, opening a new position worth an estimated $24.5M. The largest seller was Millennium Management, cutting an estimated $5.18M.

  • 109 institutional investors held Mesa Laboratories (MLAB) as of Q4 2018, up from 107 in Q3 2018.
  • Funds reported $614M of Mesa Laboratories stock for Q4 2018, up 22% quarter-over-quarter.
  • 15 funds opened new Mesa Laboratories positions in Q4 2018 and 12 closed out, a net change of +3 holders.
  • The largest Mesa Laboratories buyer in Q4 2018 was Atlanta Capital Management, an estimated $24.5M added.
  • The largest Mesa Laboratories seller in Q4 2018 was Millennium Management, an estimated $5.18M sold.

Based on aggregated 13F filings for Q4 2018.